Showing 1 - 10 of 12
Persistent link: https://www.econbiz.de/10013168327
unique reimbursement system, which results in significant differences in patients’ access to biosimilars. The importance of … securing a higher availability of these cheaper versions of biological drugs is well-recognized. The better the access to these …. The aim of this paper is to compare selected aspects of reimbursement and access to the EMA authorized biosimilar …
Persistent link: https://www.econbiz.de/10012417671
We investigate restructuring of the health system in Brazil motivated to operationalize universal health coverage. Using administrative data from multiple sources and an event study approach that exploits the staggered rollout of programmatic changes across municipalities, we find large...
Persistent link: https://www.econbiz.de/10011571857
Persistent link: https://www.econbiz.de/10012060929
Persistent link: https://www.econbiz.de/10012534298
Persistent link: https://www.econbiz.de/10012508207
Persistent link: https://www.econbiz.de/10014633345
Persistent link: https://www.econbiz.de/10014534689
Persistent link: https://www.econbiz.de/10013445433
We study the efficiency in health systems generated by community health teams, a common strategy in low- and middle-income countries for primary healthcare delivery. We exploit the rollout of a nation-wide expansion of coverage to this model in El Salvador. Using a panel dataset of...
Persistent link: https://www.econbiz.de/10014324883